within Pharmacolibrary.Drugs.ATC.L;

model L04AA06
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.94,
    Cl             = 0.00014333333333333334,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01983333333333333,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.02,
    k12             = 18.9,
    k21             = 18.9
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L04AA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Mycophenolic acid is an immunosuppressive agent that inhibits inosine monophosphate dehydrogenase, thereby blocking de novo guanosine nucleotide synthesis in T and B lymphocytes. It is used for the prevention of rejection in organ transplantation, particularly in kidney, heart, and liver transplants. The drug is approved and widely used today, often as the active metabolite of the prodrug mycophenolate mofetil.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters of mycophenolic acid after oral administration of mycophenolate mofetil (1000 mg) in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Furie, RA, et al., &amp; Malvar, A (2025). Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. <i>The New England journal of medicine</i> 392(15) 1471–1483. DOI:<a href=\"https://doi.org/10.1056/NEJMoa2410965\">10.1056/NEJMoa2410965</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39927615/\">https://pubmed.ncbi.nlm.nih.gov/39927615</a></p></li><li><p>Uchiyama, K, et al., &amp; Sugawara, M (2022). Pharmacokinetics of mycophenolic acid after haplo-hematopoietic stem cell transplantation in Japanese recipients. <i>Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners</i> 28(1) 31–38. DOI:<a href=\"https://doi.org/10.1177/1078155220980815\">10.1177/1078155220980815</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33349149/\">https://pubmed.ncbi.nlm.nih.gov/33349149</a></p></li><li><p>Zhang, D, &amp; Chow, DS (2017). Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients. <i>European journal of drug metabolism and pharmacokinetics</i> 42(2) 183–189. DOI:<a href=\"https://doi.org/10.1007/s13318-016-0378-6\">10.1007/s13318-016-0378-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27677732/\">https://pubmed.ncbi.nlm.nih.gov/27677732</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L04AA06;
